Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents

NCT00147160 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

DRUG: Temozolomide, Cisplatinum

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris